Unknown PHASE4 INTERVENTIONAL 2-arm NCT00954811

Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

A Phase IV Study on the Effect of Luteal Supplementation With Rec-LH on the Pregnancy Rate After Ovulation Triggering With GnRH-agonist Instead of HCG in IVF Protocol;Proof of Concept

Sponsor: Merck Serono International SA

Conditions Pregnancy Pregnancy Loss

Interventions 300IU rec-LH progesterone 600mg

Updated 5 times since 2017 Last updated: Jan 7, 2010 Started: Sep 30, 2005 Primary completion: Jan 31, 2008 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Pregnancy and Pregnancy Loss, this trial is ongoing. The trial is conducted by Merck Serono International SA and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Merck Serono International SA
Universitair Ziekenhuis Brussel

Data source: Universitair Ziekenhuis Brussel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium